VBS 2026 Veterinary Behaviour Symposium

Joseph Araujo, MSc., Chief Corporate Development Officer and Co-Founder, will attend the Veterinary Behavior Symposium between June 9-10 in Seattle, Washington USA. Joseph will also present new findings on “oral administration of PRI-002 and its impact on cognitive performance and cerebrospinal fluid biomarkers in aged Beagle dogs”.